Pharma channel feed – Endpoints News

Pharma channel feed

Pfizer gets an FDA win in hemophilia after a rough week

7 months ago

Valneva and Pfizer eye 2027 launch for partnered Lyme disease vaccine

7 months ago

Sanofi lands on private equity firm CD&R as potential buyer of consumer health unit

7 months ago

Teva to pay $450M to settle allegations of kickbacks and generic drug price-fixing

7 months ago

European drugmakers look to reshore manufacturing but warn of price hikes

7 months ago

Exclusive: PhRMA attacks federal government's response to rebate model for 340B

7 months ago

Updated: FDA approves Roche's new treatment for subset of breast cancer patients

7 months ago

Sen. Warren urges FTC to ‘carefully scrutinize’ Novo-Catalent deal over competition concerns

7 months ago

Exclusive: How an accidental email tipped Pfizer off to an activist investor’s plan

7 months ago

Former Pfizer CEO and CFO flip on activist and say they now support company

7 months ago

Spatial biology companies Vizgen and Ultivue merge amid ongoing lawsuits

7 months ago

CMS looks to $2 out-of-pocket cap for some commonly used generic drugs

7 months ago

GSK to pay up to $2.2B to settle almost all Zantac-related court cases

7 months ago

Major PBMs call for removing three FTC commissioners from insulin lawsuit

7 months ago

Zealand Pharma hit with second CRL for glucagon receptor agonist

7 months ago

GSK's RSV vaccine Arexvy shows long-term protection in Phase 3 trial

7 months ago

Pfizer culls RSV treatment from ReViral acquisition

7 months ago

Compounding pharmacy group sues FDA for ending Eli Lilly's GLP-1 drug shortage

7 months ago

Pfizer's former top executives pitched changes to board as part of activist's plan

7 months ago

Biogen to seek approval for high-dose Spinraza after unveiling new data

7 months ago

J&J’s ‘pretzel’ drug-device therapy fails in certain bladder cancer patients

7 months ago

Novo and Viatris settle Ozempic patent suit as generic entry date remains unknown

7 months ago

Supreme Court declines to review patent battle over inhalation powder Yutrepia

7 months ago

Pfizer targeted by activist, following post-pandemic stumbles — reports

7 months ago

First page Previous page 29 30 313233 34 35 Next page Last page